Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 57


Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology.

Manfredsson FP, Luk KC, Benskey MJ, Gezer A, Garcia J, Kuhn NC, Sandoval IM, Patterson JR, O'Mara A, Yonkers R, Kordower JH.

Neurobiol Dis. 2018 Apr;112:106-118. doi: 10.1016/j.nbd.2018.01.008. Epub 2018 Jan 16.


National Institutes of Health Research Plan on Rehabilitation: NIH Medical Rehabilitation Coordinating Committee.

NIH Medical Rehabilitation Coordinating Committee, O'Mara A, Rowland JH, Greenwell TN, Wiggs CL, Fleg J, Joseph L, McGowan J, Panagis JS, Washabaugh C, Peng GCY, Bray R, Cernich AN, Cruz TH, Marden S, Michel ME, Nitkin R, Quatrano L, Spong CY, Shekim L, Jones TLZ, Juliano-Bult D, Panchinson DM, Chen D, Jakeman L, Knebel A, Tully LA, Chan L, Damiano D, Tian B, McInnes P, Khalsa P, Reider E, Shurtleff D, Elwood W, Ballard R, Ershow AG, Begg L.

Phys Ther. 2017 Apr 1;97(4):104-407. doi: 10.1093/ptj/pzx026.


Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial.

Basch E, Pugh SL, Dueck AC, Mitchell SA, Berk L, Fogh S, Rogak LJ, Gatewood M, Reeve BB, Mendoza TR, O'Mara AM, Denicoff AM, Minasian LM, Bennett AV, Setser A, Schrag D, Roof K, Moore JK, Gergel T, Stephans K, Rimner A, DeNittis A, Bruner DW.

Int J Radiat Oncol Biol Phys. 2017 Jun 1;98(2):409-418. doi: 10.1016/j.ijrobp.2017.02.002. Epub 2017 Feb 10.


National Institutes of Health Research Plan on Rehabilitation.

NIH Medical Rehabilitation Coordinating Committee.

Arch Phys Med Rehabil. 2017 Apr;98(4):e1-e4. doi: 10.1016/j.apmr.2017.02.002.


Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials.

Basch E, Dueck AC, Rogak LJ, Minasian LM, Kelly WK, O'Mara AM, Denicoff AM, Seisler D, Atherton PJ, Paskett E, Carey L, Dickler M, Heist RS, Himelstein A, Rugo HS, Sikov WM, Socinski MA, Venook AP, Weckstein DJ, Lake DE, Biggs DD, Freedman RA, Kuzma C, Kirshner JJ, Schrag D.

JAMA Oncol. 2017 Aug 1;3(8):1043-1050. doi: 10.1001/jamaoncol.2016.6749.


Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical Trial.

Himelstein AL, Foster JC, Khatcheressian JL, Roberts JD, Seisler DK, Novotny PJ, Qin R, Go RS, Grubbs SS, O'Connor T, Velasco MR Jr, Weckstein D, O'Mara A, Loprinzi CL, Shapiro CL.

JAMA. 2017 Jan 3;317(1):48-58. doi: 10.1001/jama.2016.19425.


Low Enrollment of Adolescents and Young Adults Onto Cancer Trials: Insights From the Community Clinical Oncology Program.

Roth ME, O'Mara AM, Seibel NL, Dickens DS, Langevin AM, Pollock BH, Freyer DR.

J Oncol Pract. 2016 Apr;12(4):e388-95. doi: 10.1200/JOP.2015.009084. Epub 2016 Mar 29.


Caring for caregivers and patients: Research and clinical priorities for informal cancer caregiving.

Kent EE, Rowland JH, Northouse L, Litzelman K, Chou WY, Shelburne N, Timura C, O'Mara A, Huss K.

Cancer. 2016 Jul 1;122(13):1987-95. doi: 10.1002/cncr.29939. Epub 2016 Mar 17. Review.


Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).

Dueck AC, Mendoza TR, Mitchell SA, Reeve BB, Castro KM, Rogak LJ, Atkinson TM, Bennett AV, Denicoff AM, O'Mara AM, Li Y, Clauser SB, Bryant DM, Bearden JD 3rd, Gillis TA, Harness JK, Siegel RD, Paul DB, Cleeland CS, Schrag D, Sloan JA, Abernethy AP, Bruner DW, Minasian LM, Basch E; National Cancer Institute PRO-CTCAE Study Group.

JAMA Oncol. 2015 Nov;1(8):1051-9. doi: 10.1001/jamaoncol.2015.2639. Erratum in: JAMA Oncol. 2016 Jan;2(1):146.


Survivorship care planning: unique opportunity to champion integrative oncology?

Rowland JH, O'Mara A.

J Natl Cancer Inst Monogr. 2014 Nov;2014(50):285. doi: 10.1093/jncimonographs/lgu037. No abstract available.


What is cancer nursing research?

O'Mara A.

Cancer Nurs. 2015 Mar-Apr;38(2):81-2. doi: 10.1097/NCC.0000000000000228. No abstract available.


Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).

Basch E, Reeve BB, Mitchell SA, Clauser SB, Minasian LM, Dueck AC, Mendoza TR, Hay J, Atkinson TM, Abernethy AP, Bruner DW, Cleeland CS, Sloan JA, Chilukuri R, Baumgartner P, Denicoff A, St Germain D, O'Mara AM, Chen A, Kelaghan J, Bennett AV, Sit L, Rogak L, Barz A, Paul DB, Schrag D.

J Natl Cancer Inst. 2014 Sep 29;106(9). pii: dju244. doi: 10.1093/jnci/dju244. Print 2014 Sep.


Hypoxia induces pluripotency in primordial germ cells by HIF1α stabilization and Oct4 deregulation.

López-Iglesias P, Alcaina Y, Tapia N, Sabour D, Arauzo-Bravo MJ, Sainz de la Maza D, Berra E, O'Mara AN, Nistal M, Ortega S, Donovan PJ, Schöler HR, De Miguel MP.

Antioxid Redox Signal. 2015 Jan 20;22(3):205-23. doi: 10.1089/ars.2014.5871. Epub 2014 Oct 30.


Clinical research education: perspectives of nurses, employers, and educators.

Galassi AL, Grady MA, O'Mara AM, Ness EA, Parreco LK, Belcher AE, Hastings CE.

J Nurs Educ. 2014 Aug;53(8):466-72. doi: 10.3928/01484834-20140724-04. Epub 2014 Jul 24.


Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials.

Reeve BB, Mitchell SA, Dueck AC, Basch E, Cella D, Reilly CM, Minasian LM, Denicoff AM, O'Mara AM, Fisch MJ, Chauhan C, Aaronson NK, Coens C, Bruner DW.

J Natl Cancer Inst. 2014 Jul 8;106(7). pii: dju129. doi: 10.1093/jnci/dju129. Print 2014 Jul. Review.


Nurse scientists in cancer cooperative groups.

Bruner DW, O'Mara A.

Semin Oncol Nurs. 2014 Feb;30(1):4-10. doi: 10.1016/j.soncn.2013.12.002. Epub 2013 Dec 18. Review.


Prevalence and characteristics of moderate to severe fatigue: a multicenter study in cancer patients and survivors.

Wang XS, Zhao F, Fisch MJ, O'Mara AM, Cella D, Mendoza TR, Cleeland CS.

Cancer. 2014 Feb 1;120(3):425-32.


Predictors of significant worsening of patient-reported fatigue over a 1-month timeframe in ambulatory patients with common solid tumors.

Fisch MJ, Zhao F, O'Mara AM, Wang XS, Cella D, Cleeland CS.

Cancer. 2014 Feb 1;120(3):442-50. doi: 10.1002/cncr.28437. Epub 2013 Oct 21.


The symptom burden of cancer: Evidence for a core set of cancer-related and treatment-related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study.

Cleeland CS, Zhao F, Chang VT, Sloan JA, O'Mara AM, Gilman PB, Weiss M, Mendoza TR, Lee JW, Fisch MJ.

Cancer. 2013 Dec 15;119(24):4333-40. doi: 10.1002/cncr.28376. Epub 2013 Sep 24.


Recommendations for high-priority research on cancer-related fatigue in children and adults.

Barsevick AM, Irwin MR, Hinds P, Miller A, Berger A, Jacobsen P, Ancoli-Israel S, Reeve BB, Mustian K, O'Mara A, Lai JS, Fisch M, Cella D; National Cancer Institute Clinical Trials Planning Meeting.

J Natl Cancer Inst. 2013 Oct 2;105(19):1432-40. doi: 10.1093/jnci/djt242. Epub 2013 Sep 18.

Supplemental Content

Loading ...
Support Center